Eltrombopag Added to Standard Immunosuppressive Treatment as Front‐Line Therapy for Severe Aplastic Anemia: Long‐Term Outcomes of the Phase‐3 Randomized Superiority EBMT ‐ SAAWP RACE Study

Study limitation reported by the research below: “Age distribution of the 197 patients is not detailed in the abstract; 'mixed' age group is inferred from typical SAA trial enrollment patterns.”